These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Role of innate immunity in primary graft dysfunction after lung transplantation. Diamond JM; Wigfield CH Curr Opin Organ Transplant; 2013 Oct; 18(5):518-23. PubMed ID: 23995372 [TBL] [Abstract][Full Text] [Related]
6. Primary Graft Dysfunction (PGD) Following Lung Transplantation. Shah RJ; Diamond JM Semin Respir Crit Care Med; 2018 Apr; 39(2):148-154. PubMed ID: 29590671 [TBL] [Abstract][Full Text] [Related]
7. Incidence and severity of primary graft dysfunction after lung transplantation using rejected grafts reconditioned with ex vivo lung perfusion. Boffini M; Ricci D; Bonato R; Fanelli V; Attisani M; Ribezzo M; Solidoro P; Del Sorbo L; Ranieri VM; Rinaldi M Eur J Cardiothorac Surg; 2014 Nov; 46(5):789-93. PubMed ID: 25061216 [TBL] [Abstract][Full Text] [Related]
8. Extended post-ex vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: Results from a multicentric study. Leiva-Juárez MM; Urso A; Arango Tomás E; Lederer DJ; Sanchez P; Griffith B; Davis RD; Daneshmand M; Hartwig M; Cantu E; Weyant MJ; Bermudez C; D'Cunha J; Machuca T; Wozniak T; Lynch W; Nemeh H; Mulligan M; Song T; Jessen M; Camp PC; Caldeira C; Whitson B; Kreisel D; Ramzy D; D'Ovidio F J Heart Lung Transplant; 2020 Sep; 39(9):954-961. PubMed ID: 32475748 [TBL] [Abstract][Full Text] [Related]
9. Primary graft dysfunction after lung transplantation. Hunt ML; Cantu E Curr Opin Organ Transplant; 2023 Jun; 28(3):180-186. PubMed ID: 37053083 [TBL] [Abstract][Full Text] [Related]
10. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia. Diamond JM; Porteous MK; Roberts LJ; Wickersham N; Rushefski M; Kawut SM; Shah RJ; Cantu E; Lederer DJ; Chatterjee S; Lama VN; Bhorade S; Crespo M; McDyer J; Wille K; Orens J; Weinacker A; Arcasoy S; Shah PD; Wilkes DS; Hage C; Palmer SM; Snyder L; Calfee CS; Ware LB; Christie JD; J Heart Lung Transplant; 2016 Apr; 35(4):500-507. PubMed ID: 26856667 [TBL] [Abstract][Full Text] [Related]
11. Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation. Mizota T; Miyao M; Yamada T; Sato M; Aoyama A; Chen F; Date H; Fukuda K Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):314-20. PubMed ID: 26705301 [TBL] [Abstract][Full Text] [Related]
18. Mitigation of Primary Graft Dysfunction in Lung Transplantation: Current Understanding and Hopes for the Future. Wilkey BJ; Abrams BA Semin Cardiothorac Vasc Anesth; 2020 Mar; 24(1):54-66. PubMed ID: 31617450 [TBL] [Abstract][Full Text] [Related]
19. Severe primary graft dysfunction of the heart transplant is associated with increased plasma and intragraft proinflammatory cytokine expression. Holmström EJ; Syrjälä SO; Dhaygude K; Tuuminen R; Krebs R; Nykänen A; Lemström KB J Heart Lung Transplant; 2023 Jun; 42(6):807-818. PubMed ID: 36754701 [TBL] [Abstract][Full Text] [Related]
20. Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation. Porteous MK; Diamond JM; Christie JD Curr Opin Organ Transplant; 2015 Oct; 20(5):506-14. PubMed ID: 26262465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]